Catalyst Wire Dossier Catalyst Wire Dossier

20-valent pneumococcal conjugate vaccine

pneumococcal conjugate vaccine, 20-valent · Sanofi
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for 20-valent pneumococcal conjugate vaccine, covering 2020-11-04 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age [Phase 3]

See pricing